SynthesisBMC infectious diseases2025
Elizabethkingia in the MENA region (2000-2024): a review of distribution, antimicrobial resistance, and clinical features.
Synthesis in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Distribution of Non-Fermenting Gram-Negative Bacilli and Carbapenem Resistance Profiles in Intensive Care Units of a Foundation University Hospital: A 2023-2025 Retrospective Analysis.Medicina (Kaunas, Lithuania) · 2026Article
- Comprehensive Phenotypic Characterization of ClinicalInternational journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elizabethkingia is a family of bacteria present in the environment causing infections that have emerged as a significant clinical concern in the Middle East and North Africa region. Despite sporadic reports and case studies, the epidemiology of Elizabethkingia-encompassing its prevalence, antimicrobial resistance profiles, and clinical outcomes-remains largely anecdotal and fragmented. In this review, we systematically screened and analyzed the published literature to provide a comprehensive assessment of the distribution, antibiotic resistance characteristics, and clinical features of Elizabethkingia infections in different samples across the region. Our analysis consolidates existing evidence to highlight the true burden of Elizabethkingia and the emergence of multidrug-resistant strains. By identifying current gaps in data and standardization, this review aims to inform and engage clinicians, microbiologists, epidemiologists, and public health stakeholders in developing coordinated strategies to monitor, prevent, and manage these infections within a One Health framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.